Search

Your search keyword '"Kim, Kyung Soo"' showing total 2,500 results
Start Over Author "Kim, Kyung Soo"
2,500 results on '"Kim, Kyung Soo"'

268. Efficacy of intermittent short‐term use of a real‐time continuous glucose monitoring system in non‐insulin–treated patients with type 2 diabetes: A randomized controlled trial.

Author

Moon, Sun Joon, Kim, Kyung‐Soo, Lee, Woo Je, Lee, Mi Yeon, Vigersky, Robert, and Park, Cheol‐Young

Subjects
*TYPE 2 diabetes, *RANDOMIZED controlled trials, *BLOOD sugar monitoring, *HYPERGLYCEMIA, *PATIENT self-monitoring, *GLUCOSE
Abstract

Aim: To evaluate the efficacy of intermittent short‐term use of a real‐time continuous glucose monitoring (RT‐CGM) system in non‐insulin–treated patients with type 2 diabetes (T2D) uncontrolled with oral antidiabetic drugs (OADs). Materials and Methods: In this multicentre, randomized prospective study, 61 participants were randomly assigned to treatment group 1 (one session of RT‐CGM), treatment group 2 (two sessions of RT‐CGM with a 3‐month interval between sessions) and a control group. All participants used blinded continuous glucose monitoring for up to 6 days with education before randomization, and RT‐CGM was additionally applied for 1 week in the intervention groups. The primary outcome was change in HbA1c at 6 months. Results: Among 61 participants, 48 subjects completed the study (baseline HbA1c 8.2% ± 0.5%). At 3 months, a significant HbA1c reduction was observed in treatment group 1 (adjusted difference = −0.60%, P =.044) and treatment group 2 (adjusted difference = −0.64%, P =.014) compared with the control group. However, at 6 months, only treatment group 2 achieved a significant HbA1c reduction (adjusted difference = −0.68%, P =.018). Especially in the treatment groups, patients performing self‐monitoring of blood glucose (SMBG) at least 1.5 times/day showed a significant HbA1c improvement, at both 3 and 6 months, but those performing SMBG less than 1.5 times/day showed no significant improvement. Conclusions: In non‐insulin–treated patients with T2D uncontrolled with OADs, intermittent short‐term use of RT‐CGM was an effective method for glucose control, especially in those performing SMBG frequently. [ABSTRACT FROM AUTHOR]

Published
2023
Full Text
View/download PDF

269. Prolonged Use of Carnitine-Orotate Complex (Godex ®) Is Associated with Improved Mortality: A Nationwide Cohort Study.

Author

Park, Kye-Yeung, Hong, Sangmo, Kim, Kyung-Soo, Han, Kyungdo, and Park, Cheol-Young

Subjects
COHORT analysis, TYPE 2 diabetes, NATIONAL competency-based educational tests, FATTY liver, PERIODIC health examinations, HEPATOTOXICOLOGY
Abstract

Despite its hepatoprotective effects and favorable metabolic effects, the association between carnitine-orotate complex (Godex®) intake and mortality has never been investigated. We enrolled 13,413 adults who underwent national health examination and were prescribed the carnitine-orotate complex. Subjects were classified into three groups based on duration of using carnitine-orotate complex: <30, 30–180, and ≥180 days and were followed-up until 2019. Hazard ratios (HRs) and 95% confidence intervals (CIs) for all-cause mortality were estimated using Cox proportional hazards regression. During the follow-up period, 708 deaths were documented. Adjusted HR of mortality was 0.69 (95% CI 0.51–0.92) in those who used carnitine-orotate complex for ≥180 days compared to those who used it for <30 days. Use of carnitine-orotate complex for ≥180 days was associated with significantly reduced mortality in individuals with metabolic risk factors such as obesity, metabolic syndrome, dyslipidemia, and fatty liver than the shorter period of use. A significant interaction was observed in individuals with type 2 diabetes (HR 0.43, 95% CI 0.29–0.63, p-value 0.001). In this nationwide study, longer use of carnitine-orotate complex was associated with improved mortality compared to a shorter period of use, and the risk reductions were prominent in individuals with metabolic risk factors. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

300. Tubeless video-assisted thoracic surgery for pulmonary ground-glass nodules: expert consensus and protocol (Guangzhou)

Author

He, Jianxing, primary, Liang, Hengrui, additional, Wang, Wei, additional, Akopov, Andrey, additional, Aiolfi, Alberto, additional, Ang, Keng-Leong, additional, Bertolaccini, Luca, additional, Cai, Kaican, additional, Cao, Qingdong, additional, Chen, Baojun, additional, Chen, Chang, additional, Chen, Chun, additional, Chen, Donglai, additional, Chen, Fengxia, additional, Chen, Jun, additional, Chen, Lei, additional, Chen, Mingwu, additional, Chen, Yongbing, additional, Chen, Zhuxing, additional, Cheng, Chao, additional, Cui, Dong, additional, Cui, Fei, additional, Dai, Tianyang, additional, Dong, Qinglong, additional, Ferrari, Paolo A., additional, Flores, Raja M., additional, Fu, Junke, additional, Funaki, Soichiro, additional, Froudarakis, Marios E., additional, Gan, Xiangfeng, additional, Geng, Mingfei, additional, Guo, Jialong, additional, Guo, Qiang, additional, Han, Yongtao, additional, He, Jintao, additional, He, Kaiming, additional, Hirai, Kyoji, additional, Hu, Jian, additional, Hu, Shuqiao, additional, Huang, Jian, additional, Huang, Jun, additional, Jiang, Wenfa, additional, Kim, Kyung Soo, additional, Kiss, Gabor, additional, Kong, Fanyi, additional, Lan, Lan, additional, Leng, Xuefeng, additional, Li, Bin, additional, Li, Gaofeng, additional, Li, Hecheng, additional, Li, Hefei, additional, Li, Heng, additional, Li, Jiwei, additional, Li, Xiaoqiang, additional, Li, Shuben, additional, Li, Yinfen, additional, Li, Zhuoyi, additional, Liang, Yi, additional, Liang, Lixia, additional, Liang, Wenhua, additional, Liao, Yongde, additional, Lin, Wanli, additional, Lin, Xu, additional, Liu, Hongxu, additional, Liu, Hui, additional, Liu, Jixian, additional, Liu, Jun, additional, Liu, Xiang, additional, Liu, Zihao, additional, Lu, Xingzhao, additional, Luo, Qingquan, additional, Mao, Naiquan, additional, Pan, Qi, additional, Pang, Dazhi, additional, Peng, Jun, additional, Pompeo, Eugenio, additional, Qian, Rulin, additional, Qiao, Kun, additional, Redwan, Bassam, additional, Sang, Zi, additional, Shao, Wenlong, additional, Shen, Jianfei, additional, Shen, Weiyu, additional, Sung, Sook-Whan, additional, Tang, Wenfang, additional, Wang, Tianhu, additional, Wang, Guangsuo, additional, Wang, Haitao, additional, Wang, Huien, additional, Wang, Jiyong, additional, Wang, Wen, additional, Wang, Yongyong, additional, Wang, Zhenyuan, additional, Wei, Li, additional, Wei, Wei, additional, Wu, Hao, additional, Wu, Jie, additional, Xia, Zhaohua, additional, Xu, Chenyang, additional, Xu, Enwu, additional, Xu, Hai, additional, Xu, Ning, additional, Xu, Quan, additional, Xu, Rongyu, additional, Xu, Shun, additional, Yang, Chaokun, additional, Yang, Hanyu, additional, Yang, Shengli, additional, Yi, Jun, additional, Zhang, Guangjian, additional, Zhang, Hao, additional, Zhang, Jia, additional, Zhang, Man, additional, Zhang, Xiao, additional, Zhang, Yajie, additional, Zhang, Zhe, additional, Zhang, Zhifeng, additional, Zhao, Honglin, additional, Zhao, Jian, additional, Zhao, Xiaodong, additional, Zhou, Jianping, additional, Zhou, Yanran, additional, Zhu, Chengchu, additional, Zhu, Shaojin, additional, Zhu, Xinhai, additional, Cui, Jian, additional, Yan, Yubo, additional, and Chen, Ke-Neng, additional

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results